Stock Market

Saakshi Medtech Acquires 34.41% Stake in Laxmi Engineering for ₹41.87 Cr; Stock Rallies 56% in Six Months

Alex Smith

Alex Smith

20 hours ago

4 min read 👁 2 views
Saakshi Medtech Acquires 34.41% Stake in Laxmi Engineering for ₹41.87 Cr; Stock Rallies 56% in Six Months

Synopsis: Saakshi Medtech and Panels Limited has approved the acquisition of a 34.41 percent equity stake in Laxmi Engineering Industries Bhopal Pvt Ltd for approximately Rs. 41.87 crore through a share swap arrangement. The acquisition is aimed at expanding the company’s presence in the broader industrial engineering and heavy equipment segment while reducing dependence on its existing business verticals.

Saakshi Medtech has a total market capitalization of Rs. 476.71 crore, according to data on the NSE. Saakshi Medtechshares were trading at Rs. 270 apiece on the National Stock Exchange, up by 2.25 percent; the stock has gained around 10.72 percent over the last five sessions, while it has surged about 37.40 percent in the 30 days. Over a six-month period, the stock has given a return of 56.02 percent, whereas on a year-on-year basis it has gone up nearly 83.80 percent, reflecting exceptional overall performance. The stock’s 52-week high was Rs. 276 and 52-week low was Rs. 118.

Saakshi Medtech and Panels Limited has announced that its Board of Directors has approved the acquisition of a 34.41 percent equity stake in Laxmi Engineering Industries Bhopal Pvt Ltd (LEI), an engineering company engaged in the manufacturing of customized heat transfer equipment and heavy engineering solutions. The acquisition will be carried out through a share swap transaction valued at approximately Rs. 41.87 crore.

Under the transaction structure, Saakshi Medtech will issue 20,22,940 equity shares in exchange for acquiring 23,92,850 equity shares of the target company. Following the completion of the transaction, Saakshi Medtech will hold a 34.41 percent stake in Laxmi Engineering Industries.

Laxmi Engineering Industries operates in the heat exchanger and heavy engineering segment and manufactures products such as shell and tube heat exchangers, surface condensers, feed water heaters, pressure vessels, deaerators and other fabricated engineering equipment used across sectors including power generation, oil & gas, chemicals, fertilizers, cement and industrial process industries.

The acquisition appears to be part of Saakshi Medtech’s broader strategy to diversify into adjacent engineering and industrial infrastructure segments. While the company’s current operations are focused primarily on electrical panels and related systems, the addition of a heat transfer and heavy engineering business allows it to expand into complementary industrial applications and reduce dependence on a single business segment.

A key strategic advantage of the acquisition is access to a wider industrial customer base. Laxmi Engineering Industries has established relationships with several reputed public sector undertakings and engineering companies including BHEL, NTPC, GAIL, IOCL, L&T and Mitsubishi. This could potentially create cross-selling opportunities and strengthen Saakshi Medtech’s positioning within the industrial engineering ecosystem.

The target company also possesses strong technical capabilities in thermal design, fabrication and engineering along with export exposure across regions such as the Middle East, South Asia and Eurasia. The acquisition may therefore help Saakshi Medtech expand its technological expertise and project execution capabilities over time.

From an industry perspective, India’s heavy engineering and industrial equipment sector continues to benefit from rising infrastructure investments, power sector expansion, refinery projects, renewable energy growth and industrial manufacturing activity. Heat exchangers and thermal engineering systems are critical components in energy recovery and industrial process operations, providing long-term demand visibility for companies operating in this segment.

The use of a share swap structure instead of an all-cash acquisition also indicates a relatively balanced capital allocation strategy, as it allows the company to pursue expansion while preserving liquidity and minimizing immediate cash outflow.

However, investors may closely monitor how effectively the company integrates the acquired business and whether the strategic partnership translates into higher revenue growth, operational synergies and improved profitability in the coming years. Since the acquisition involves a minority stake rather than full ownership, immediate financial consolidation benefits may remain limited initially.

Overall, the acquisition reflects Saakshi Medtech’s strategic intent to evolve into a broader industrial engineering player by expanding into complementary infrastructure and heavy engineering businesses with long-term growth potential.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Saakshi Medtech Acquires 34.41% Stake in Laxmi Engineering for ₹41.87 Cr; Stock Rallies 56% in Six Months appeared first on Trade Brains.

Related Articles